Risk factors and prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis

doi:10.4253/wjge.v18.i3.115736

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 3

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (61)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=40

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=16

Mar 16, 2026 (publication date) through Mar 18, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Endosc. Mar 16, 2026; 18(3): 115736
Published online Mar 16, 2026. doi: 10.4253/wjge.v18.i3.115736

Open in New Tab Full Size Figure Download Figure

Figure 1 Overview of risk factors and evidence-based prevention strategies for post-endoscopic retrograde cholangiopancreatography pancreatitis. BMI: Body mass index; SOD: Sphincter of Oddi dysfunction; PEP: Post-endoscopic retrograde cholangiopancreatography pancreatitis; NSAID: Non-steroidal anti-inflammatory drug; PD: Pancreatic duct.

Citation: Xu PW, Xu QQ, Yu Y, Jiao Y, Liu YH, Yang L. Risk factors and prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc 2026; 18(3): 115736
URL: https://www.wjgnet.com/1948-5190/full/v18/i3/115736.htm
DOI: https://dx.doi.org/10.4253/wjge.v18.i3.115736